References for "Improving Outcomes"

1.  Circulation. 2007 Jul 24;116:427-33.  Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Becattini C, Vedovati MC, Agnelli G.

2.  Am J Emerg Med. 2007 25:138-43.  Can elevated troponin I levels predict complicated clinical course and inhospital mortality in patients with acute pulmonary embolism? Aksay E, Yanturali S, Kiyan S.

3.  Georgian Med News. 2007 146:29-31. Troponin-I and creatine kinase-mb values for detection of cardiovascular system damage in children with recurrent respiratory tract disease Tsabutashvili AV, Barabadze KN, Vekua MV.

4.  Ann Clin Biochem. 2007 44:391-3. Cardiac troponin I concentrations in people presenting with diabetic ketoacidosis. Geddes J, Deans KA, Cormack A, et al. 

5.  Circ J. 2007 71:1047-51.  Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Kuwabara Y, Sato Y, Miyamoto T, et al.

6. Angiology. 2007 Oct-Nov;58:603-9. Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study. Demir M, Kanadasi M, Akpinar O, et al.

7.  Clin Chem. 2008 54:747-51. Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?    Kavsak PA, Newman AM, Ko DT, Palomaki GE

8.  Hepatology. 2007 Jun;45(6):1489-95. Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Parekh NK, Hynan LS, De Lemos J, et al.

9.  Clin Chim Acta. 2007 382:106-11. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score. Kuklinska AM, Sobkowicz B, Mroczko B, et al.

10.  Int J Cardiol. 2007 ;115:386-90. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M, Filipiak KJ, Malek LA, et al.

11.  Clin Chim Acta. 2007 Sep;384:24-7. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Lee YW, Kim HJ, Cho YH, et al.

12.  Cerebrovasc Dis. 2007;23:216-20. Ischemia-modified albumin in acute stroke. Abboud H, Labreuche J, Meseguer E, et al.

13.  Clin Lab Anal. 2008;22(1):45-9. Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. Liyan C, Jie Z, Yonghua W, et al.

15.  Heart. 2007 93:16-21. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Núñez J, Núñez E, Consuegra L, et al.

16.  Hellenic J Cardiol. 2006 47:269-74. Clinical and prognostic value of elevated CA125 levels in patients with congestive heart failure. Kouris NT, Kontogianni DD, Papoulia EP, et al.

17.  Int J Cardiol. 2007 117:370-2. Pregnancy-associated plasma protein-A: an emerging cardiac biomarker. Thorn EM, Khan IA.

18. Int J Cardiol. 2007 117:365-9. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Elesber AA, Lerman A, Denktas AE, et al.

19.  Int J Cardiol. 2007 117:333-9. Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Chalikias GK, Tziakas DN, Kaski JC,et al. 

20.   Atherosclerosis. 2007 193:196-203. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Tziakas DN, Chalikias GK, Kaski JC, et al.